(Q40281819)

English

The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer

scientific article published on October 2006

Statements

The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer (English)
Mara Rendi
Nanjoo Suh
Darlene B Royce
Renee Risingsong
Charlotte R Williams
William Lamph
Fernand Labrie
Stan Krajewski
Xiaochun Xu
Heetae Kim
Powel Brown
Michael B Sporn
1 October 2006
5902-5909

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit